KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $747,000.

  • Twist Bioscience's Other Non-Current Liabilities rose 83.54% to $747,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $747,000, marking a year-over-year increase of 83.54%. This contributed to the annual value of $747,000 for FY2025, which is 83.54% up from last year.
  • Per Twist Bioscience's latest filing, its Other Non-Current Liabilities stood at $747,000 for Q3 2025, which was up 8.58% from $688,000 recorded in Q2 2025.
  • Twist Bioscience's 5-year Other Non-Current Liabilities high stood at $28.4 million for Q4 2021, and its period low was $60,000 during Q3 2022.
  • For the 3-year period, Twist Bioscience's Other Non-Current Liabilities averaged around $435,273, with its median value being $451,000 (2025).
  • In the last 5 years, Twist Bioscience's Other Non-Current Liabilities soared by 13,408.57% in 2021 and then tumbled by 99.79% in 2022.
  • Over the past 5 years, Twist Bioscience's Other Non-Current Liabilities (Quarterly) stood at $28.4 million in 2021, then tumbled by 99.79% to $60,000 in 2022, then surged by 691.67% to $475,000 in 2023, then decreased by 14.32% to $407,000 in 2024, then skyrocketed by 83.54% to $747,000 in 2025.
  • Its Other Non-Current Liabilities stands at $747,000 for Q3 2025, versus $688,000 for Q2 2025 and $451,000 for Q1 2025.